2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Not yet recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 3 | Completed 2, Unknown 1 |
Follow T-cell Large Granular Lymphocytic Leukemia: new trials by email Literature Review of T-cell Large Granular Lymphocytic Leukemia trials Research Report on T-cell Large Granular Lymphocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia Golidocitinib - Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocytic Leukemia | Phase 2 | Not yet recruiting | Washington University School of Medicine | 24 | 2026-09-30 | 2026-07-06 |
| A Registry for People With T-cell Lymphoma Optional Blood Sample and Nail Sample - T-cell Lymphoma, NK-Cell Lymphoma | Recruiting | Memorial Sloan Kettering Cancer Center | 1000 | 2023-07-27 | 2026-05-20 | |
| ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL) ABC008 - T-cell Large Granular Lymphocytic Leukemia | Phase 1 / Phase 2 | Completed | Abcuro, Inc. | 21 | 2022-09-28 | 2026-05-06 |
| CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma anti-CD7 CAR-pNK cells - Acute Myeloid Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-03-01 | 2016-12-06 |
| Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia MTX followed by fludarabine - T-Cell Large Granular Lymphocytic Leukemia | Phase 2 | Terminated | German CLL Study Group | 12 | 2005-06-01 | 2016-10-03 |
| Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia Hu-MiK-Beta-1 - T-Cell Large Granular Lymphocytic Leukemia, Leukemia, T-Cell Large Granular Lymphocytic | Phase 1 | Completed | National Cancer Institute (NCI) | 9 | 2004-03-01 | 2019-01-11 |
Leukemia, Large Granular Lymphocytic (6) · Enteropathy-Associated T-Cell Lymphoma (2) · Immunoblastic Lymphadenopathy (2) · Leukemia, Prolymphocytic, T-Cell (2) · Lymphoma, Extranodal NK-T-Cell (2) · Lymphoma, T-Cell (2) · Lymphoma, T-Cell, Cutaneous (2) · Mycosis Fungoides (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Sezary Syndrome (2) · Anemia (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Large-Cell, Anaplastic (1)
Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6) · Leukemia, T-Cell (6) · Lymphatic Diseases (6) · Lymphoproliferative Disorders (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Leukemia (5) · Leukemia, Lymphoid (5) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Leukemia, Prolymphocytic (2) · Lymphadenopathy (2)
Hu-Mik-beta-1 monoclonal antibody (1) · Methotrexate (1) · Sensitivity and Specificity (1) · fludarabine phosphate (1)
Abcuro, Inc. (1) · German CLL Study Group (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1) · Washington University School of Medicine (1)
United States (4) · China (1) · Germany (1)
Lin Yang, Ph.D. (1) · Michael Kneba (1) · Neha Mehta-Shah, MD (1) · Steven Horwitz, MD (1) · Thomas A Waldmann, M.D. (1)